The authors emphasize that none of the studies examined metformin as a treatment for already-established long COVID. Rather, ...

Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and well-established medication, significantly reduces the risk of developing long COVID ...

Two major trials show metformin taken during acute COVID-19 lowers long COVID risk, is safe, and could be added to outpatient ...

A. Metformin has long been a first-line medication for Type 2 diabetes, but it is certainly not the only drug that can help control blood sugar. Ask your doctor whether sitagliptin or liraglutide ...

Researchers say the type 2 diabetes medication metformin may help treat age-related macular degeneration, which could prevent ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Julia Naftulin Every time Julia publishes a story, you’ll get an alert straight to your inbox!

Doctors are finding new hope for people at risk of losing their sight from age-related macular degeneration, or AMD. Research from the University of Liverpool suggests that metformin, a long-used ...

Metformin may reduce the risk of intermediate AMD by 37% in diabetic patients over 55. The study analyzed ocular images from 2,000 patients over five years, adjusting for key variables. Metformin's ...

Metformin started for pre-diabetes also appeared to reduce patients' risk of developing gout, researchers found. Among 1,154 people with elevated hemoglobin A1c (HbA1c) just short of the threshold for ...

A five-year image-based study in people with type 2 diabetes found metformin use was associated with lower odds of developing ...